Florian Huemer

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

Leora Horn, Aaron S. Mansfield, Aleksandra Szczęsna et al. · New England Journal of Medicine · 2018 · 3.3K citations · Full text

Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer

Florian Huemer, Gabriel Rinnerthaler, Theresa Westphal et al. · Oncotarget · 2018 · 88 citations · Full text

Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade

Florian Huemer, David Lang, Theresa Westphal et al. · Journal of Clinical Medicine · 2019 · 73 citations · Full text

Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study

Martin Reck, Rafał Dziadziuszko, Shunichi Sugawara et al. · Lung Cancer · 2024 · 49 citations

Oncology, Five-year Survival, Phase Iii Imbrella +7

Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI

Thomas Melchardt, Katharina Troppan, Clemens Hufnagl et al. · Journal of the National Comprehensive Cancer Network · 2015 · 45 citations · Full text